Human umbilical cord CD146 mesenchymal stem cells (Beijing Sanlikang Cell Tech)

人脐带CD146间充质干细胞（北京三有利康细胞）

Report date: 2025/09/25 13:47:06

Base Information

Drug NameHuman umbilical cord CD146 mesenchymal stem cells (Beijing Sanlikang Cell Tech)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsIschemic Stroke

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesBeijing Sanlikang Cell Technology Co., Ltd.

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Sanlikang Cell Technology Co., Ltd.

Inactive CompaniesN/A

Active IndicationsIschemic Stroke

Inactive IndicationsN/A

Other Information

ATC CodeN/A